Medtronic: Revenue for 2025 reached 447 million yuan, a year-on-year increase of 62.79%.

Medei Medical announced that in 2025, the company achieved operating income of 447.41 million yuan, a year-on-year increase of 62.79%; net profit attributable to owners of the parent company was 65.26 million yuan, turning losses into profits. At the end of the reporting period, the company's total assets were 1.19 billion yuan, up 12.69% year-on-year; equity attributable to owners of the parent company was 862.40 million yuan, up 6.46% year-on-year. The main reason for the performance growth was the company's overall production planning, adherence to innovation, and strong development of blood purification and pharmaceutical equipment combination intelligent equipment business, with a significant increase in revenue from pharmaceutical equipment combination intelligent equipment. The data is unaudited, subject to the annual report.